Advance Program | ADA 82nd Scientific Sessions - 29

ADVANCE PROGRAM
* Inpatient Education-Teaching Staff
with a Focus on Hospital Systems
Diabetes Technology in the Inpatient
Setting-What the Bedside Staff
Needs to Know
Jane Jeffrie Seley, DNP, MPH, MSN,
GNP, RN, BC-ADM, CDCES, CDTC
Automated Insulin Delivery Systems in
the Hospital-Say What?
Rebecca L. Longo, ACNP-BC, MSN,
CDE
Teaching Safety-How to Prevent
Sentinel Events for Malglycemia
Leigh B. Bak, MSN, ACNS-BC,
CDCES
DKA Readmission Reduction-
Teaching DKA Prevention to Patients
AND Nurses
Lisa Diaz, MSN, APRN, ACNS-BC,
CDCES
* Disparities in the Use of Diabetes
Medications and Technologies
Limitations in Access to New Insulin
Therapies across Different Ethnicities
Sara Jane Cromer, MD
Racial and Ethnic Disparities in Efficacy
and Use of Diabetes Medications
Colette Dejong, MD
Racial and Ethnic Disparities in the
use of Diabetes Technology-How
to Avoid Health Inequalities in DM
Technology
Diana Naranjo, PhD
* The Future of Insulin-Weekly, Oral,
Smart, or Interchangeable Therapies
Weekly Insulins on the Horizon
Harpreet S. Bajaj, MD, MPH
A Pill to Swallow-Oral Insulins
George Grunberger, MD
Making Insulin Smarter-GlucoseSensitive
Insulin
Michael A. Weiss, MD, PhD, MBA
Insulin Access & Affordability-The
Role of Biosimilars and Interchangeable
Insulins
Rita Rastogi Kalyani, MD, MHS
* Non-coding Genetic Variation in
Diabetes and Obesity
State-of-the-Art Lecture-Lessons
Learned from FTO
Marcelo Nobrega, MD, PhD
The Non-coding Genome-A
Repository for Variation Affecting
Obesity and Diabetes
Ruth Loos, PhD
The Non-coding Genome in the
Pancreatic Islets and Elsewhere in
Diabetes
Michael L. Stitzel, PhD
The Role of Epigenetics-Beyond
the Genome-In Disease Risk and
Therapy
Patrick Gaffney, MD
* Primary Prevention of Obesity-The
Importance of Population Level
Interventions
What Are Population-Level
Interventions for Obesity Prevention
and What Value Do They Bring?
Methods-The Evidence Base for
Population Level Interventions for
Obesity Prevention-Turning the
Evidence-Based Medicine Paradigm on
its Head
David Ogilvie, PhD
Food/Beverage Taxes-(Examples
from Philadelphia, Berkeley, Chicago)
Anna Grummon, PhD
Front of Pack Labeling-Experience
from Chile
Lindsey Smith-Taillie, PhD
Marketing Regulation
Jennifer L. Harris, PhD, MBA
Question and Discussion Period
* Translating Stem Cell-Derived
Islets to a Cell Therapy for Diabetes
What makes a ß-Cell a ß-Cell?
Alvin C. Powers, MD
Genome Editing to Advance ß-Cell
Therapy
Senta Georgia, PhD
Circadian Entrainment Triggers In Vitro
Maturation of Stem-Cell-Derived
Islets
Juan R. Alvarez-Dominguez, PhD
Preclinical Assessment of Stem-Cell
Derived Islet Function in a Non-Human
Primate Model
Jose Oberholzer, MD, MHCM, FACS
* Oral Presentations
10:10 a.m.-11:45 a.m.
* National Scientific & Health Care
Achievement Awards Presentation
* Outstanding Scientific Achievement
Award Lecture
Anna Gloyn, PhD
12:00 p.m.-1:00 p.m.
* Professional Interest Group
Discussion on Diabetes
Technology-Optimizing EMR
Integration of CGM Data
Introduction
Optimizing EMR integration of CGM
Data
Richard M. Bergenstal, MD
Juan Espinoza, MD
* Professional Interest Group
Discussion on Health Care Delivery
and Quality Improvement
Introduction
Mary K. Rhee, MD, MSc
Approaches to Supporting Primary
Care in Providing Quality Diabetes Care
Question and Answer Period
* Professional Interest Group
Discussion on Pregnancy and
Reproductive Health
Introduction
Jennifer Wyckoff, MD
Why the 2 Step Method Is Best for
Diagnosing GDM
Ebony B. Carter, MD, MPH
Why the 1 Step Method Is Best for
Diagnosing GDM
Fidelma P. Dunne, PhD
Question and Discussion Period
HYBRID | NEW ORLEANS | JUNE 3-7, 2022 | #ADA2022
Speakers and presentation titles are subject to change.
29
Advance Program | ADA 82nd Scientific Sessions

Table of Contents for the Digital Edition of Advance Program | ADA 82nd Scientific Sessions
